In March 2024, Wegovy was also approved to reduce the risk of cardiovascular death, heart attack and stroke in adults with cardiovascular (heart, blood vessel) disease and either obesity or overweight
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used to manage type 2 diabetes and aid in weight loss, particularly for individuals facing obesity
10.1016/j.ejphar.2019.01.030 65 SeverM.KlicekR.RadicB.BrcicL.ZoricicI.DrmicD.et al (2009)
Dipeptidyl peptidase IV inhibition attenuates blood pressure rising in young spontaneously hypertensive rats
4 Potential toxicity, safety and bioavailability Mustard is one of the most significant food allergens in the world and may cause severe allergic reactions in sensitized individuals [95]
Weight loss patients may notice reduced hunger, fewer cravings, and improved portion control